Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

WBI-1001 for psoriasis completes key preclinical studies

Oct. 24, 2006

Positive preclinical findings for Apollo's topical psoriasis treatment

Oct. 20, 2006

ProtoKinetix reports recent findings with AAGP

Oct. 19, 2006

New peptides for treating wrinkles reported by Rohto

Oct. 18, 2006

New data presented at EADV on agents under development at Barrier Therapeutics

Oct. 18, 2006

Novel wound-healing agents disclosed in recent Northwestern University patent

Oct. 13, 2006

Biovitrum and Synphora sign agreement on JB-991 for psoriasis

Oct. 13, 2006

Preclinical data of Basilea's novel macrolide BAL-19403 presented

Oct. 11, 2006

Sinclair Pharma and Intendis sign marketing agreement for Atopiclair

Oct. 11, 2006

Canadian clearance for second phase III study of ISA-247 in psoriasis

Oct. 6, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...